Trial · NCT00577863
Registered outcomes36
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
21 to 36 of 36
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Secondary | Summary of Subject Perception (Attributes) Assessments - Easy to Remove a Used Needle | 8 weeks | To assess overall subject perception of the device performance and acceptability through a questionnaire completed by all subjects at Visit 3. Subject perception of how easy it was to remove a used needle. |
| Secondary | Summary of Subject Perception (Attributes) Assessments - Easy to Set the Dose | 8 weeks | To assess overall subject perception of the device performance and acceptability through a questionnaire completed by all subjects at Visit 3. Subject perception of how easy it was to set the dose. |
| Secondary | Summary of Subject Perception (Attributes) Assessments - Easy to Push the Black Injections Button to Administer the Dose | 8 weeks | To assess overall subject perception of the device performance and acceptability through a questionnaire completed by all subjects at Visit 3. Subject perception of how easy it was to push the black injections button to administer the dose. |
| Secondary | Summary of Subject Perceptions (Attributes) Assessments - Easy to Hold the Pen While Injecting | 8 weeks | To assess overall subject perception of the device performance and acceptability through a questionnaire completed by all subjects at Visit 3. Subject perception of how easy it was to hold the pen while injecting. |
| Secondary | Summary of Subject Perception (Attributes) Assessments - Easy to Use the Forteo B Pen Instructions For Use | 8 weeks | To assess overall subject perception of the device performance and acceptability through a questionnaire completed by all subjects at Visit 3. Subject perception of how easy it was to use the Forteo B Pen Instructions for Use. |
| Secondary | Summary of Subject Perception (Attributes) Assessments - Overall Ease of Use | 8 weeks | To assess overall subject perception of the device performance and acceptability through a questionnaire completed by all subjects at Visit 3. Subject perception of the overall ease of use. |
| Secondary | Summary of Subject Perception (Attributes) Assessments - To What Extent Are You Satisfied With the Forteo B Pen | 8 weeks | To assess overall subject perception of the device performance and acceptability through a questionnaire completed by all subjects at Visit 3. Subject perception of how satisfied they were with the Forteo B Pen. |
| Secondary | Summary of Subject Perception (Attributes) Assessments - How Confident Are You That You Receive the Medication With Your Forteo B Pen | 8 weeks | To assess overall subject perception of the device performance and acceptability through a questionnaire completed by all subjects at Visit 3. Subject perception of how confident they were that they received the medication with the Forteo B Pen. |
| Secondary | Summary of Subject Perception (Attributes) Assessments - Convenient for Me to Use | 8 weeks | To assess overall subject perception of the device performance and acceptability through a questionnaire completed by all subjects at Visit 3. Subject perception of how convenient Forteo B Pen was to use. |
| Secondary | Summary of Subject Perception (Attributes) Assessments - Reduces My Reluctance to Take Injections | 8 weeks | To assess overall subject perception of the device performance and acceptability through a questionnaire completed by all subjects at Visit 3. Subject perception of whether the Forteo B Pen reduces their reluctance to take injections. |
| Secondary | Summary of Subject Perception (Attributes) Assessments - Helps Me Manage My Osteoporosis At Home | 8 weeks | To assess overall subject perception of the device performance and acceptability through a questionnaire completed by all subjects at Visit 3. Subject perception of whether the Forteo B Pen helps them manage their osteoporosis when they are at home. |
| Secondary | Summary of Subject Perception (Attributes) Assessments - Helps Me Manage My Osteoporosis Away From Home | 8 weeks | To assess overall subject perception of the device performance and acceptability through a questionnaire completed by all subjects at Visit 3. Subject perception of whether the Forteo B Pen helps them manage their osteoporosis when they are away from home. |
| Secondary | Summary of Subject Perception (Attributes) Assessments - Reusing Needles | 8 weeks | To assess overall subject perception of the device performance and acceptability through a questionnaire completed by all subjects at Visit 3. Subject response on whether or not they sometimes reuse needles. |
| Secondary | Summary of Subject Perception (Attributes) Assessments - When Do You Attach a Needle | 8 weeks | To assess overall subject perception of the device performance and acceptability through a questionnaire completed by all subjects at Visit 3. Subject response on when they attach a needle to their Forteo B Pen. |
| Secondary | Summary of Subject Perception (Attributes) Assessments - When Do You Remove the Needle | 8 weeks | To assess overall subject perception of the device performance and acceptability through a questionnaire completed by all subjects at Visit 3. Subject response on when they remove the needle from their Forteo B Pen. |
| Secondary | Summary of Subject Perception (Attributes) Assessments - What Could Be Done to Improve the Forteo B Pen Instructions For Use | 8 weeks | To assess overall subject perception of the device performance and acceptability through a questionnaire completed by all subjects at Visit 3. Subject perception of what could be done to improve the Forteo B Pen Instructions for Use. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00577863/registered?page=2